Overview

An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With Rosacea

Status:
Completed
Trial end date:
2018-03-30
Target enrollment:
Participant gender:
Summary
the study will measure the decrease in redness on the face of rosacea subjects
Phase:
Phase 3
Details
Lead Sponsor:
Padagis LLC
Perrigo Company
Treatments:
Oxymetazoline
Phenylephrine